Physiologic Role of Type 2 Deiodinase in Skeletal Muscle
2 型脱碘酶在骨骼肌中的生理作用
基本信息
- 批准号:7018448
- 负责人:
- 金额:$ 13.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-20 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:bioenergeticsclinical researchenzyme activitygene expressiongenetic manipulationgenetic modelsgenetically modified animalsglucose metabolismhormone regulation /control mechanismhuman tissueiodide peroxidaselaboratory mousepeptide hormone biosynthesispostmortemstriated musclesthyroid hormonesthyroxinetissue /cell culturetriiodothyronine
项目摘要
DESCRIPTION (provided by applicant):
The goal of the work described in this proposal is to characterize the physiologic role of the type 2 deiodinase (D2) in human skeletal muscle. D2 converts the prohormone thyroxine (T4) to 3,5,3'-triiodothyronine (T3), the active hormone. Our hypothesis is that, in human skeletal muscle, D2 regulates T3- responsive metabolic pathways by modulating the saturation of nuclear T3-receptors (TRs). This hypothesis is founded on data from brain, pituitary, and brown adipose tissue showing that D2-catalyzed T4 to T3 conversion is an important source of intranuclear T3, and on the literature establishing T3 as an important regulator of metabolic processes in skeletal muscle. Our approach to test this hypothesis primarily utilizes commercially available primary human skeletal myocytes in culture (HSMM cells), but also includes a new transgenic "SkD2" mouse with conditional, skeletal muscle-specific expression of D2. In Specific Aim I, we will characterize the regulation of D2 in human skeletal myocytes, and then test the hypothesis that D2- catalyzed T4 to T3 conversion can increase nuclear T3 concentration in these cells enough to alter the expression of T3-responsive genes. In Specific Aim II, we will evaluate the potential for T4, via D2, to modulate intermediary metabolism in these cells. In Specific Aim III, we will create a transgenic mouse with conditional expression of D2 in its skeletal muscle via the tet-off system. We will use this mouse to study the physiologic role of skeletal muscle D2 under normal conditions and during periods of metabolic stress. In addition, we will determine the effect of D2 induction on in vivo glucose homeostasis in collaboration with Dr. Jason Kim of the Yale Mouse Metabolic Phenotypic Center. These studies will provide the candidate with experience in a wide range of molecular biological techniques. He will become an expert in thyroid hormone action, while also gaining valuable exposure in the areas of energetics and metabolism, positioning him well to continue his development towards becoming an independent investigator in endocrinology.
描述(由申请人提供):
本提案中描述的工作的目标是表征2型脱碘酶(D2)在人类骨骼肌中的生理作用。D2将甲状腺素原(T4)转化为活性激素3,5,3 '-三碘甲状腺原氨酸(T3)。我们的假设是,在人类骨骼肌中,D2通过调节核T3受体(TRs)的饱和度来调节T3响应性代谢途径。这一假设是建立在脑,垂体和棕色脂肪组织的数据表明,D2催化的T4到T3的转换是核内T3的重要来源,并在文献上建立T3作为骨骼肌代谢过程的重要调节剂。我们测试这一假设的方法主要利用商业上可获得的原代人骨骼肌细胞培养(HSMM细胞),但也包括一个新的转基因“SkD 2”小鼠与条件,骨骼肌特异性表达的D2。在特定目标I中,我们将描述D2在人骨骼肌细胞中的调节,然后测试D2催化的T4至T3转化可以增加这些细胞中的核T3浓度足以改变T3响应基因的表达的假设。在特定目标II中,我们将评估T4通过D2调节这些细胞中间代谢的潜力。在Specific Aim III中,我们将通过tet-off系统创建在其骨骼肌中具有条件性表达D2的转基因小鼠。我们将使用这只小鼠来研究正常条件下和代谢应激期间骨骼肌D2的生理作用。此外,我们将与耶鲁大学小鼠代谢表型中心的Jason Kim博士合作,确定D2诱导对体内葡萄糖稳态的影响。这些研究将为候选人提供广泛的分子生物学技术经验。他将成为甲状腺激素作用的专家,同时也在能量学和代谢领域获得宝贵的曝光,使他能够继续发展成为内分泌学的独立研究者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRIAN W KIM其他文献
BRIAN W KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRIAN W KIM', 18)}}的其他基金
Physiologic Role of Type 2 Deiodinase in Skeletal Muscle
2 型脱碘酶在骨骼肌中的生理作用
- 批准号:
7558968 - 财政年份:2005
- 资助金额:
$ 13.39万 - 项目类别:
Physiologic Role of Type 2 Deiodinase in Skeletal Muscle
2 型脱碘酶在骨骼肌中的生理作用
- 批准号:
6873386 - 财政年份:2005
- 资助金额:
$ 13.39万 - 项目类别:
Physiologic Role of Type 2 Deiodinase in Skeletal Muscle
2 型脱碘酶在骨骼肌中的生理作用
- 批准号:
7179346 - 财政年份:2005
- 资助金额:
$ 13.39万 - 项目类别:
Physiologic Role of Type 2 Deiodinase in Skeletal Muscle
2 型脱碘酶在骨骼肌中的生理作用
- 批准号:
7340684 - 财政年份:2005
- 资助金额:
$ 13.39万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 13.39万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 13.39万 - 项目类别:














{{item.name}}会员




